ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00244257
Recruitment Status : Terminated (Study terminated due to low enrollment.)
First Posted : October 26, 2005
Last Update Posted : April 9, 2015
Sponsor:
Information provided by (Responsible Party):
Sanofi ( Genzyme, a Sanofi Company )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2008
  Actual Study Completion Date : July 2008